[{"address1": "343 Oyster Point Boulevard", "address2": "Suite 200", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 870 1000", "website": "https://www.calithera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Ms. Stephanie  Wong CPA", "age": 50, "title": "CFO & Secretary", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 752416, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher J. Molineaux Ph.D.", "age": 71, "title": "Senior Vice President of Development", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 405000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frank  Parlati Ph.D.", "age": 55, "title": "Senior Vice President of Research", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "open": 0.01, "dayLow": 0.01, "dayHigh": 0.01, "regularMarketOpen": 0.01, "regularMarketDayLow": 0.01, "regularMarketDayHigh": 0.01, "beta": -1.134, "forwardPE": -0.00014814814, "volume": 10000, "regularMarketVolume": 10000, "averageVolume": 3073, "averageVolume10days": 963, "averageDailyVolume10Day": 963, "bidSize": 1100, "askSize": 1000, "marketCap": 974, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.12, "fiftyDayAverage": 0.002572, "twoHundredDayAverage": 0.01228525, "trailingAnnualDividendYield": "NaN", "currency": "USD", "enterpriseValue": -1442025, "floatShares": 4827378, "sharesOutstanding": 4872500, "sharesShort": 417277, "sharesShortPriorMonth": 148514, "sharesShortPreviousMonthDate": 1671062400, "dateShortInterest": 1673568000, "sharesPercentSharesOut": 0.0857, "heldPercentInsiders": 0.00926, "shortRatio": 0.78, "shortPercentOfFloat": 0.0892, "impliedSharesOutstanding": 4873330, "bookValue": -0.401, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -21290000, "trailingEps": -7.94, "forwardEps": -1.35, "lastSplitFactor": "1:20", "lastSplitDate": 1655251200, "enterpriseToEbitda": 0.034, "52WeekChange": -0.9936, "SandP52WeekChange": 0.23631513, "exchange": "OEM", "quoteType": "EQUITY", "symbol": "CALA", "underlyingSymbol": "CALA", "shortName": "Calithera Biosciences, Inc.", "longName": "Calithera Biosciences, Inc.", "firstTradeDateEpochUtc": 1412256600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a8222980-ce54-3c9b-b7e4-d20f5251b3ff", "messageBoardId": "finmb_109127589", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0002, "recommendationKey": "none", "totalCash": 25451000, "totalCashPerShare": 5.223, "ebitda": -41819000, "totalDebt": 1666000, "quickRatio": 3.444, "currentRatio": 3.603, "debtToEquity": 8.17, "returnOnAssets": -0.5629, "returnOnEquity": -1.1414, "grossProfits": -28533000, "freeCashflow": -28174250, "operatingCashflow": -43608000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]